All In Biotech

Drug Trial Radar · NCT07531251

Clinical Trial in Patients With Barth Syndrome- 4TAZPower

Phase 3b/4, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Trial to Evaluate the Efficacy and Safety of Daily Subcutaneous Injections of Elamipretide in Patients With Genetically Confirmed Barth Syndrome

Last checked: Nov 20, 2026Latest source record: Nov 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

48

Planned (sponsor's estimate)

Start

Jul 2, 2026

Primary completion

Sep 30, 2029

Study completion Nov 30, 2029

Sponsor

Lead sponsor
Stealth BioTherapeutics Inc.Industry
Sponsor type
Industry
First posted
Apr 15, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
Male only, from 5 years, up to 55 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Phase 3b/4, randomized, double-blind, parallel-group, placebo-controlled clinical trial to evaluate the efficacy, safety, and pharmacokinetics of a once daily SC injection of elamipretide in subjects with genetically confirmed BTHS for 72 weeks. The primary trial objective is to confirm the efficacy of elamipretide which is approved in the United States(FORZINITY™) under the accelerated approval based on an improvement in knee extensor muscle strength, an intermediate clinical endpoint.

Conditions

  • Barth Syndrome

Interventions

  • ElamipretideDrug

    sub cutaneous injection

  • PlaceboDrug

    sub cutaneous injection

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Primary Efficacy End PointTime frame: 72 weeks

Locations

4 sites in 4 countries. Site status is shown where the registry gives one.

  • Trial Not Offered in the U.S

    Needham, Massachusetts · Terminated

  • Children's Hospital of Westmead

    Westmead, North South Wales, Australia · Recruiting

  • Metabolics and Genetics in Canada (MAGIC)

    Calgary, Alberta, Canada · Recruiting

  • Bristol Royal Hospital for Children Upper Maudlin Street Paul O'Gorman Building

    Bristol, United Kingdom · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.